rs114024716
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002476.2(MYL4):c.314-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,611,708 control chromosomes in the GnomAD database, including 121 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002476.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL4 | NM_002476.2 | c.314-4G>A | splice_region_variant, intron_variant | ENST00000393450.5 | NP_002467.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL4 | ENST00000393450.5 | c.314-4G>A | splice_region_variant, intron_variant | 1 | NM_002476.2 | ENSP00000377096.1 |
Frequencies
GnomAD3 genomes AF: 0.0155 AC: 2360AN: 152192Hom.: 54 Cov.: 32
GnomAD3 exomes AF: 0.00409 AC: 1023AN: 249994Hom.: 31 AF XY: 0.00285 AC XY: 385AN XY: 135048
GnomAD4 exome AF: 0.00155 AC: 2259AN: 1459398Hom.: 66 Cov.: 31 AF XY: 0.00130 AC XY: 946AN XY: 725688
GnomAD4 genome AF: 0.0155 AC: 2368AN: 152310Hom.: 55 Cov.: 32 AF XY: 0.0146 AC XY: 1088AN XY: 74490
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Atrial fibrillation, familial, 18 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
MYL4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at